TurmXTRA
Commercial- Indications
- Inflammation
Company intelligence / Profile preview
Nutriventia has developed and commercialized several branded nutraceutical ingredients using proprietary drug delivery technologies. Their flagship product TurmXTRA® has demonstrated high bioavailability at low doses in clinical studies and supports musculoskeletal health. The company’s products are clinically validated and have received industry recognition for innovation in formulation science. They focus on solving formulation challenges like poor solubility or palatability to deliver more effective dietary supplements with improved compliance and consumer experience.
3 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nutriventia.